$32.64 -0.40 (-1.21%)
11/6/2009 4:00 PM

Illumina, Inc. (ILMN)

CAPS Rating: 4 out of 5

The Company is a developer, manufacturer and marketer of next-generation life-science tools and integrated systems for the analysis of genetic variation and biological function.

Current Price $32.64 Mkt Cap $4.05B
Open $32.75 P/E Ratio 41.30
Prev. Close $33.04 Div. (Yield) N/A (N/A)
Daily Range $32.01 - $32.83 Volume 1,540,706
52-Wk Range $18.82 - $44.07 Avg. Daily Vol. 2,496,000

ILMN News and Commentary

Caps

How do you think ILMN will perform vs the S&P 500?

Add Stock to Watchlist

All Members

522 Outperform
44 Underperform
 

All-Star Members

164 Outperform
17 Underperform
 

Wall Street

16 Outperform
1 Underperform
 

Top ILMN Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

coryjobe (91.22)
Submitted May 17, 2009

develops next-generation tools for large scale analysis of genetic variation and function, for improving drugs and therapies, customizing diagnoses and treatment, and curing disease.

Managed to increase revenues despite a difficult… More

TMFBreakerThiel (93.43)
Submitted August 28, 2006

Really, it's not the 255 P/E or the recent downgrade or the tireless hype. But can anyone who has read the recent Markman opinion on its litigation with Affymetrix not be at least a LITTLE bit worried? The trial starts in October, people.

ILMN VS S&P 500 (SPY)

Recent Community Commentary

Read the most recent pitches from members about ILMN.

Recs

0
Member Avatar proisback (26.41) Submitted: 10/4/2009 8:22:10 PM : Underperform Start Price: $42.35 ILMN Score: +27.04

The PE is well into the nose bleed zone, while insider are very active sellers. Any slight misses or advances by competitors will cause decent size decline.

Recs

0
Member Avatar ecofarmerboy33 (< 20) Submitted: 9/16/2009 11:17:23 AM : Outperform Start Price: $37.60 ILMN Score: -14.42

ILMN is making a strong push for 100 gigabyte runs by 12/31/09 and is consistently hitting 50 gigabyte runs in labs around the globe. Amazingly high throughput will result in faster and more efficient research runs leading to sooner commerical and pharma application - which means more market penetration and higher earnings.

Recs

0
Member Avatar MajorBob04 (59.10) Submitted: 9/14/2009 11:47:57 PM : Outperform Start Price: $36.96 ILMN Score: -13.79

National Healthcare

Leaderboard

Find the members with the highest scoring picks in ILMN.

Score Leader

CantFindAUsernam

CantFindAUsernam (< 20) Score: +152.80

The Score Leader is the member with the highest score across all their picks in ILMN.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
S&P
Gain
Score Commentary
OSUChad 83.92 3/15/2007 Outperform 1Y $14.57 +123.95% -18.60% +142.54
dancon7 < 20 3/16/2007 Outperform 5Y $14.65 +122.87% -18.70% +141.57
fishman888 70.01 3/16/2007 Outperform 1Y $14.65 +122.87% -18.70% +141.57
dancesct 85.40 3/19/2007 Outperform 1Y $14.69 +122.19% -18.67% +140.86 1 Comment
oncmd 64.03 3/26/2007 Outperform 5Y $14.97 +118.11% -21.07% +139.18
25000THEVA < 20 3/22/2007 Outperform NS $15.23 +114.31% -21.06% +135.38
mapssi 42.23 4/13/2007 Outperform 3W $15.55 +109.97% -21.62% +131.59 1 Comment
redbellini < 20 3/6/2007 Outperform 3M $15.47 +110.99% -18.47% +129.46
Brad2007 54.15 4/20/2007 Outperform NS $15.88 +105.54% -23.50% +129.04
nachlat 60.79 4/10/2007 Outperform 3Y $15.81 +106.45% -21.74% +128.19

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
S&P
Gain
Score End Date Commentary
TrackCarisandCo 78.62 10/28/2009 Outperform NS $34.41 -5.14% +0.92% -6.07
TrackAurigaU.S.A 26.23 7/9/2009 Outperform NS $32.46 +0.55% +21.52% -20.97
TrackBarclaysCap 86.02 7/2/2009 Outperform NS $33.87 -3.63% +18.98% -22.62
TrackWedbush < 20 4/22/2009 Outperform NS $35.00 -6.74% +28.37% -35.12
TrackRWBaird 85.02 12/15/2008 Outperform NS $21.11 +63.00% +19.16% +43.84 10/28/2009 @ $34.41
TrackGlobalCrown < 20 11/7/2008 Outperform NS $27.72 +17.75% +19.94% -2.20
TrackJPMorgan 78.71 1/29/2008 Outperform NS $32.65 -0.03% -17.69% +17.66
TrackGarpResearc 86.48 1/11/2008 Outperform NS $35.98 -9.28% -20.69% +11.41
TrackLehmanBros 76.60 1/11/2008 Outperform NS $35.98 -9.28% -20.69% +11.41
TrackUBS 86.41 1/11/2008 Outperform NS $35.98 -9.28% -20.69% +11.41
TrackCanaccord 84.17 9/11/2007 Outperform NS $25.62 +27.40% -23.25% +50.65
TrackLeerinkSwan 84.26 7/25/2007 Outperform NS $22.67 +43.98% -25.88% +69.86
TrackCowenandCo 74.62 7/25/2007 Outperform NS $22.75 +43.47% -25.82% +69.29
TrackPacificGrow 90.86 7/23/2007 Outperform NS $21.07 +54.95% -26.88% +81.83
TrackBearStearns 86.38 6/14/2007 Outperform NS $19.69 +65.77% -25.52% +91.29
TrackMatrix 89.45 6/13/2007 Outperform NS $19.29 +69.21% -24.74% +93.95
TrackDeutscheSec 89.50 2/7/2007 Outperform NS $18.31 +78.26% -21.65% +99.91
TrackJimCramer < 20 2/2/2007 Underperform 3W $18.58 +75.63% -21.48% -97.10
TrackJimCramer < 20 1/25/2007 Outperform 3W $20.04 -7.26% +1.79% -9.05 2/3/2007 @ $18.58
TrackJimCramer < 20 10/18/2006 Underperform 3W $21.89 -8.45% +3.65% +12.11 1/26/2007 @ $20.04
TrackCarisandCo 78.62 8/21/2006 Outperform NS $16.90 +107.10% -35.03% +142.13 4/22/2009 @ $35.00

Featured Broker Partners